Literature DB >> 2450279

Antigen chimaeras of poliovirus as potential new vaccines.

K L Burke1, G Dunn, M Ferguson, P D Minor, J W Almond.   

Abstract

Polioviruses occur as three distinct serotypes, 1, 2 and 3, and are composed of a single-stranded positive-sense RNA genome of approximately 7,450 nucleotides enclosed in an icosahedral particle of diameter 27 nm. The three-dimensional crystallographic structure of poliovirus type 1 has been determined at 2.9 A resolution, providing a detailed knowledge of the folding and arrangement of the individual virus proteins, VP1-VP4. From this and the characterization of monoclonal antibody-resistant mutants, the amino acids contributing to antigenic sites have been identified and located on the surface of the virus particle. Here we describe the construction and characterization of a poliovirus chimaera having a defined region of type 3 inserted into type 1. This virus has composite antigenicity and the substitute site is immunogenic in small animals and primates. The ability to construct such viruses has implications for the design of improved poliovirus vaccine strains or vaccines against other picornaviruses, such as hepatitis A.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450279     DOI: 10.1038/332081a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  48 in total

1.  Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.

Authors:  Javier Martín; Elena Samoilovich; Glynis Dunn; Angie Lackenby; Esphir Feldman; Alan Heath; Ekaterina Svirchevskaya; Gill Cooper; Marina Yermalovich; Philip D Minor
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.

Authors:  Ke Lyu; Ya-Ling He; Hao-Yang Li; Rong Chen
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

Review 3.  Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations.

Authors:  D T O'Hagan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

4.  Mapping of a neutralizing antigenic site of Coxsackievirus B4 by construction of an antigen chimera.

Authors:  B Y Reimann; R Zell; R Kandolf
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Toward a poliovirus-based simian immunodeficiency virus vaccine: correlation between genetic stability and immunogenicity.

Authors:  S Tang; R van Rij; D Silvera; R Andino
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Polioviruses containing picornavirus type 1 and/or type 2 internal ribosomal entry site elements: genetic hybrids and the expression of a foreign gene.

Authors:  L Alexander; H H Lu; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

7.  Immunization against rabies with plant-derived antigen.

Authors:  A Modelska; B Dietzschold; N Sleysh; Z F Fu; K Steplewski; D C Hooper; H Koprowski; V Yusibov
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

8.  Crystal structures of enterovirus 71 (EV71) recombinant virus particles provide insights into vaccine design.

Authors:  Ke Lyu; Guang-Chuan Wang; Ya-Ling He; Jian-Feng Han; Qing Ye; Cheng-Feng Qin; Rong Chen
Journal:  J Biol Chem       Date:  2014-12-09       Impact factor: 5.157

9.  Theiler's virus as a vector for foreign gene delivery.

Authors:  L Zhang; S Sato; J I Kim; R P Roos
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge.

Authors:  N L Davis; K W Brown; R E Johnston
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.